+ All Categories
Home > Documents > Pi is 0002937813006261

Pi is 0002937813006261

Date post: 22-Feb-2018
Category:
Upload: indah-maulana-sari
View: 218 times
Download: 0 times
Share this document with a friend

of 17

Transcript
  • 7/24/2019 Pi is 0002937813006261

    1/17490.e1 American Journal of Obstetrics & Gynecology NOVEME! "01#

    !

    $G$ %a&ers '''.AJOG.org

    $urgical site infection after (ysterectomyAeuMuro Gas(a' )a*e+ M,- Alean/ra M. Mc%enco'+ M,- Ma/eline A. ,ic*iascoec(ea+ M,-

    ,eanna . Martin+ M%2- Elisabet( A. Ere*son+ M,+ M%2

    OJE35VE6 Our ob7ecti8e 'as to estimate t(e occurrence of surgical site infections $$5: after (ysterectomy an/ t(e associate/ ris*

    factors.

    $;,< ,E$5GN6 =e con/ucte/ a crosssectional analysis of t(e"00>

    "009 American 3ollege of $urgeons National $urgical ?uality

    n @ ""1 'omen:. !is* factors t(at 'ere associate/ 'it( cellulitis'ere route of (ysterectomy 'it( an a/7uste/ o//s ratio 9AO!: of #.4

    9>B confi/ence inter8al C35D+ "."e."":for la&arotomy com&are/

    'it( t(e 8aginal a&&roac(+ o&erati8e time F>t( &ercentileAO!+

    1.4- 9>B 35+ 1.40e".44:+American $ociety of Anest(esia class #"

    5m&ro8ement %rogram &artici&ant use /ata files to analyHe (ysterec 9AO!+ 1.9- 9>B 35+ 1.#1e".4#:+bo/y mass in/e 40*gIm

    9AO!+

    tomies. ,ifferent routes of (ysterectomy 'ere com&are/. (e&rimaryoutcome 'as to i/entify t(e occurrence of #0/ay su&erficial $$5cellulitis: after (ysterectomy. $econ/ary outcomes 'ere t(e occur

    rence of /ee an/ organs&ace $$5 after (ysterectomy. )ogisticregression mo/els 'ere con/ucte/ to furt(er e&lore t(e associationsof ris*s factors 'it( $$5 after (ysterectomy.

    !E$;)$6 A total of 1#+"" 'omen 'ere inclu/e/ in our final analysis.

    (e occurrence of &osto&erati8e cellulitis after (ysterectomy 'as

    1.B

    ".>- 9>B 35+ 1.>e#.0:+ an/ /iabetes mellitus 9AO!+ 1.>4- 9>B35+

    1.0e"."4: (e occurrence of /ee& an/ organs&ace $$5 'as

    1.1B n @ 1>4 'omen: after (ysterectomy.

    3ON3);$5ON6 Our fin/ing of t(e /ecrease/ occurrence of su&erficial

    $$5 after t(e 8aginal a&&roac( for (ysterectomy reaffirms t(e role for

    8aginal (ysterectomy as t(e route of c(oice for (ysterectomy.

    ey 'or/s6 (ysterectomy+ outcome+ &osto&erati8e com&lication+surgical site infection

    3ite t(is article as6 )a*e AG+ Mc%enco' AM+ ,ic*iascoec(ea MA+ et al. $urgical site infection after (ysterectomy. Am J Obstet Gynecol "01#-"096490.e19.

    ecently+ ;nite/ $tates (ealt(care

    initiati8es sonsore/ by t(e 3en

    ters for Me/icare an/ Me/icai/ $er8ices3M$: an/ t(e Joint 3ommission on

    t(e Accre/itation of 2ealt(care Organi

    Hations (a8e targete/ &re8entable

    (os&ital acuire/ infections+ suc( as

    ostoerati8e surgical site infections

    $$5:+ as a riority in imro8ing atient

    safety. Effecti8e January "01"+ 3M$

    reuire/ all Me/icare certiKe/

    (ositals to ublically re&ort clinical

    /ata an/ outcome measures in a

    L$ystematic 3linical ,atabase !egistry for

    General $urgery in t(e 2os&ital5n&atient

    ?uality !eorting %rogram.1

    (e

    conse uence for an institution or

    (osital not reorting 'ill be aayment enalty as of October "01#.

    (e " surgical roce/ures t(at 'ere

    i/entiKe/ by 3M$ in t(is recent

    man/ate for &ublic re&orting of

    ostoerati8e $$5 are colon surgeryan/ (ysterectomy.

    O8er t(e last " /eca/es+ remar*able

    a/8ancements (a8e been ma/e in t(e

    c(oice of (ysterectomy routes. Alt(oug(t(e occurrence an/ ris* factors of

    $$5 after total ab/ominal (ysterectomy

    A2: (as been reorte/+" neit(er t(e

    occurrence nor t(e ris* factors of&ost

    (ysterectomy $$5 (a8e been reorte/

    by (ysterectomy route."4 etter un/erstan/ing of ris* factors for $$5 after

    (ysterectomy can (el target efforts at

    t(e re/uction of mo/iKable ris*s to

    re8ent infections. A//itionally+ un/er

    stan/ing ris* factors for $$5 after

    (ysterectomy can lea/ to better ris*

    stratiKcation in t(e reorting of uality

    outcomes. Our ob7ecti8e 'as to estimate

    t(e occurrence of #0/ay ostoerati8e

    $$5 after all routes of (ysterectomy an/to i/entify associate/ ris* factors.

    rom t(e ,eartment of Obstetrics+ Gynecology+ an/ !ero/ucti8e $ciences+

  • 7/24/2019 Pi is 0002937813006261

    2/17NOVEME! "01# American Journal of Obstetrics & Gynecology 490.e"

    MAE!5A)$ AN, ME2O,$=e con/ucte/ a secon/ary /atabase analysis of t(e "00>"009 American 3ollege

    of $urgeons National $urgical ?uality 5mro8ement %rogram A3$ N$?5%:

    articiantuse /ata Kles to analyHe t(e /ata of 'omen '(o un/er 'ent

    (ysterectomies erforme/ by gy necologic ser8ices. (e A3$ N$?5% is a

    national rogram for surgical uality

    imro8ement t(at collects uniform /ata

    on atients '(o un/ergo surgical&ro

    ce/ures. 2osital articiation in t(e

    A3$ N$?5% rogram is 8oluntary an/

    000"9#IP#.00 Q "01# Mosby+ 5nc. All rig(ts reser8e/. (tt& 6 II/./oi.or g I10.101I7.a7og."01#.0.01 conK/ential. (is information is col

    lecte/ by a formal c(art re8ie' rocess

    http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.018http://dx.doi.org/10.1016/j.ajog.2013.06.018
  • 7/24/2019 Pi is 0002937813006261

    3/17

    $G$ %a&ers '''.AJO G .org

    A)E 1

    ,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8esuerficial surgical site infection after (ysterectomy n C1#+"" 'omen:

    an/ its uality control measures are

    furt(er /escribe/ on t(eir 'ebsite

    (t t6 II'' ' .a c sns i .o r g:. Eemtion

    status for t(is stu/y 'as obtaine/ in

    'riting from t(e .4: "> 0.: .49

    Et(nicity6 2is&anic+ n B: " 1".": "10 1.0: .14

    ,iabetes mellitus+ n B: 41 1.: 9" ."B: R .001

    Eclusion criteria inclu/e/ 1:

    male se+ ": 'omen 'it( t(e

    /iagnosis of current &regnancy+ #:

    surgical &roce/ure 'it(in #0 /ays

    before (ysterectomy+ 4: 3urrent

    %roce/ural erminology 3o/ing $ystem+

    4t( e/ition 3%4:+ co/e incon sistent

    'it( (ysterectomy+ >: 3%4 co/e t(at

    in/icates el8ic eenteration &roce

    2istory of cerebro8ascular acci/ent'it( neurologic /eficit+ n B:

    1 0.>: > 0.>B: 1.0 /ure at t(e time of (ysterectomy+ an/ :

    'omen 'it( a /iagnosis of reoerati8e3urrent smo*er+ n B: >1 "#.1: "1 19.B: ."0

    o/y mass in/e+ n B: R .001

    R#0 *gIm"

    #>.#: >9 >>.9:

    #0 an/ R40 *gIm"

    4 ##.>: 4>4 ##.:

    40 *gIm"

    9 #1.": 14#9 10.:

    Ascites+ n B: ".: 104 0.: R .01

    a

    infection t(at inclu/es sesis+ systemic

    inammatory resonse syn/rome+ an/

    setic s(oc* imme/iately before (yster

    ectomy. After eclusion for t(ese

    criteria+ t(e remaining articiants

    'ere 'omen '(o un/er'ent

    (ysterectomy.

    2ysterectomy route 'as assigne/

    base/on 3%4 co/ing of t(e rimary&ro

    ;nintentional 'eig(t loss+ n B:

    unctional status6 /e&en/ent for acti8itiesof /aily li8ing+ n B:

    2ysterectomy for gynecologiccancer+ n B:

    %reo&erati8e anemia6 (ematocrit9R#B:+n B:

    %reo&erati8e creatinine le8elF1.>mgI/)+ n B:

    American $ociety of Anest(esiologists

    class #+ n B:

    4 1.: " 0.>: .0"

    " 0.9: 9 0.: .

    #" 14.>: 1 .4: R .001

    4 "".#: "9 "".: .94

    # 1.: > 0.9: .1

    9# 4".1: ">"1 1.>: R .001

    ce/ure6 A2+ ab/ominal

    suracer8ical (ysterectomy $32:+

    total 8aginal (ys terectomy V2:+

    laaroscoicassiste/ 8aginal

    (ysterectomy )AV2:+ total laa

    roscoic (ysterectomy )2:+ an/

    laa roscoic $32 )A$32:. =e

    furt(er eamine/ $$5 base/ onab/ominal in cisions6 1: laarotomy

    A2 or $32:+ ": laaroscoic

    incisions )AV2+ )2+ or )A$32:+ or

    #: V2. inally+ 'e eamine/ $$5

    base/ on 8aginal cuff in

    5ntrao&erati8e bloo/ transfusion+ n B: 1> .: #"9 ".4: R .001

    b

    cisions6 1: no 8aginal cuff incisions $32

    or )A$32: 8s ": 8aginal cuff incisions

    =or* relati8e 8alue unit

    O&erati8e time F>t(&ercentile/uration+ n B:

    1. >.1 1.# #. R .001

    9# 4".1: ## "4.: R .001

    A2+ V2+ )AV2+ an/ )2:.

    !is* factors for $$5 'ere elore/

    an/ groue/ into t(e follo'ingcategories6

    y&e of anest(esia6 general+ n B: ""1 100.0: 1#+111 9.4: .001

    http://www.ajog.org/http://www.ajog.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.acsnsqip.org/http://www.ajog.org/
  • 7/24/2019 Pi is 0002937813006261

    4/17

    $G$ %a&ers'''.AJOG.org=oun/ class+ n B: .0

    13lean 0 ## 0.":

    "3leanIcontaminate/ "1> 9.#: 1#+44# 9.:

    #3ontaminate/ > ".#: 9" 0.:

    4,irty 1 0.>: ## 0.":

    a)oss of 10B of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-

    b,ata are gi8en as mean $,.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

    /emogra(ic features+ reoerati8e

    me/ ical comorbi/ities+ an/

    intraoerati8e factors. ,emogra(ic

    features inclu/e/ age+ race+ an/

    et(nicity. =omen 'ere /ic(otomiHe/

    into t(e " age categories R0 yearsol/ an/ 0 years ol/: because of a

    re8iously /emonstrate/ nonlinear

    association bet'een age an/ t(e log

    o//s of ostoerati8e infection.

    %reoerati8e comorbi/ities inclu/e/

    me/ical /iag noses+ obesity+

    (ysterectomy for gyneco logic

    cancer+ reoerati8e functionalin a//ition to a #0/ay &osto&era

    ti8e follo'u e8aluation of atients.>

    Variables t(at are collecte/ inclu/e

    reoerati8e c(aracteristics+ surgical in

    formation+ an/ #0/ay ostoerati8e

    com&lications. (e A3$ N$?5%

    /atabase

    status+ unintentional 'eig(t loss+

    &reo& erati8e laboratory /ata+ an/

    American $ociety of Anest(esia A$A:

    classiKcation.

    http://www.ajog.org/http://www.ajog.org/
  • 7/24/2019 Pi is 0002937813006261

    5/17

    Me/ical /iagnoses t(at 'ere

    consi/ere/ inclu/e/ /iabetes mellitus+ a

    (istory of cerebro8ascular acci/ents

    3VA: 'it( neurologic /eKcit+ ascites+

    reoerati8e corticosteroi/ use+ an/

    obesity. Obesity 'as classiKe/ base/ on

    bo/y mass in/e M5:. =omen 'erecategoriHe/ as (a8 ing normal 'eig(t

    M5+ R#0 *gIm":+ obesity M5+ #0

    an/ R40 *gIm":+ an/ morbi/ obesity

    M5+ 40 *gIm":.

    =omen '(o (a/ un/ergone (ysterec

    tomies for gynecologic cancer 'ere

    i/en tiKe/ by 3%4 co/es t(at 'ere

    consistent 'it( lym( no/e /issection

    or ra/ical /ebul*ing+ t(e /iagnoses of

    reoerati8e ascites+ reoerati8e

    /isseminate/ cancer+ reoerati8e

    c(emot(eray+ an/ &reo& erati8era/iation t(era&y. unctionalstatus 'as

    /eKne/ as a 'omanSs ability to

    erform acti8ities of /aily li8ing+

    '(ic( inclu/e/ bat(ing+ fee/ing+

    /ressing+ toi leting+ an/ mobility an/

    'as categoriHe/ as eit(er in/een/ent

    or /een/ent. ;n intentional 'eig(t

    loss 'as use/ as a mar*er of frailty

    an/ 'as /eKne/ as loss of F10B of

    bo/y'eig(t o8er t(e re8ious

    mont(s. %reoerati8e laboratory /ata

    'ere use/ to i/entify anemia an/ renalcomromise. Anemia 'as /eKne/ as

    (e matocrit of R#B base/ on t(e

    Kn/ings of =u et al

    an/ 2eisler et

    al.9

    !enal com&romise 'as /eKne/ as a

    creatinine le8el of F1.>mgI/) base/ on

    t(e Kn/ings of ,o'/y et al.10

    5ntraoerati8e factors t(at 'ere

    elore/ inclu/e/ t(e tye of

    /ata Kle of t(e A3$ N$?5%.1"

    (ese

    /eKnitions 'ere also base/ on criteria

    set by t(e 3enters for ,isease 3ontrol

    an/ %re8ention 3,3:.1#

    (e rimary

    outcome 'as t(e occurrence of #0/ay

    suerKcial $$5 cellulitis: after (ys

    terectomy. 3ellulitis 'as /eKne/ as an

    infection t(at in8ol8e/ only s*in or

    subcutaneous tissue of t(e surgical inci

    sion. $econ/ary outcomes 'ere t(e

    occurrence of /ee an/ organsace

    $$5 an/ urinary tract infection ;5:

    after (ysterectomy. ,ee an/ organ

    sace $$5 inclu/e/ infections t(at

    in8ol8e/ /ee soft tissues fascia an/

    muscle: at an/ aroun/ t(e surgical

    incision an/ in fections in any art

    of t(e bo/y t(at 'as oene/ or

    maniulate/ /uringt(e oerati8e roce/ure. (is inclu/es

    8aginal cuff cellulitis an/ 8aginal cuff

    abscess+ eritonitis+ an/ el8ic abscess.

    ,ee an/ organsace $$5 'ere consi/ere/ as 1 category+because t(ese " cate

    gories 'ere /ifKcult to /istinguis( '(en

    (ysterectomy is consi/ere/ to be t(e

    rimary roce/ure. inally+ 'e eam

    ine/ ostoerati8e ;5+ '(ic( 'as

    /eKne/ by 3,3 criteria for

    symtomatic ;5 an/ asymtomatic

    bacteriuria+ '(ic( ta*e into accountt(e recent use of in/'elling cat(eters

    an/ t(e age of t(e&atient.1#

    A)E "

    ,escriti8e statistics+ $tu/ent t test+

    %earson c"+ an/ is(er eact test"si/e/: 'ere erforme/ for bi8ariate

    analysis. (ree logistic regression mo/els

    'ere con/ucte/ to furt(er elore t(e

    associations of ris*s factors for

    cellulitis+ /ee an/ organsace $$5+an/ &ost oerati8e ;5 after

    (ysterectomy.+9

    Variables t(at 'ere associate/ 'it(

    $$5 'ere i/entiKe/ for otential

    inclusion in t(e Knal mo/el base/ on

    bi8ariate analysis % R .1:. Variables

    'ere a//e/ to t(e mo/el in a

    ste'ise fas(ion 'it( t(e use of

    for'ar/ selection %.0>:. A/7uste/ o//s ratios AO!s:

    an/

    9>B conK/ence inter8als 35s: 'erecalculate/. $tatistical analysis 'as &er

    forme/ 'it( $AA statistical

    soft'are 8ersion 11.0- $tata

    3ororation+ 3ollege $tation+ T: an/

    $A$ statistical soft'are 8ersion 9."-

    $A$ 5nstitute 5nc+ 3ary+ N3:.

    !E$;)$A total of "#+>9 articiants 'ere

    classiKe/ as (a8ing un/ergone a gyne

    cologic roce/ure in t(e "00>

    "009A3$ N$?5% articiant use /ataset.

    (e follo'ing eclusions 'ere ma/e

    from t(e Knal analysis6 1: male se

    n @ >1:+ ": 'omen 'it( t(e /iagnosis

    of current regnancy n @ 41:+ #:

    surgical roce/ure 'it(in #0 /ays

    anest(esia+ 'oun/ classiKcation+ intra

    oerati8e bloo/ transfusion+ an/ &roce

    /ural /ifKculty. 3oncomitant roce/ures

    an/ roce/ural /ifKculty 'ereaccounte/ for by an eamination of t(e

    total 'or* relati8e 8alue units an/

    total oerati8e time. %roce/ures (a/

    bet'een 1 an/

    3% co/es. o consi/er t(e com&leity

    of all t(e /ifferent &ossible

    combinations of

    )ogistic regression mo/el for association of cellulitis after (ysterectomy

    Variable A/7uste/ o//s ratio 9>B 35 % 8alue

    !oute of (ysterectomy

    otal 8aginal (ysterectomy referent: 1 U U

    )aarotomya

    #.4 "."e."" R .001

    )a&arosco&ic incisionsb

    1.4> 0.#e".> ."0

    O&erati8e time F>t(&ercentile /uration 1.4 1.40e".44 R .001

    roce/ures+ 'or* relati8e 8alue units

    for all concomitant roce/ures 'ere

    totale/. Oerati8e time 'as

    categoriHe/ as a

    American $ociety of Anest(esiologists

    class #

    o/y mass in/e+ *gIm"

    1.9 1.#1e".4# R .001

    /ic(otomous 8ariable abo8e an/ belo'

    t(e >t( ercentile+ base/ on

    &re8ious 'or*by 3ul8er et al+11

    '(o

    /emonstrate/ t(at o&erati8e time ofF

    >t(&ercentileisa ris* factor for $$5. or(ysterectomies in t(e A3$ N$?5% /ataset+ t(e o&erati8e time ofF>t(&ercentile 'as 149 minutes. $$5 categories 'ere /eKne/ by t(e criteria foun/

  • 7/24/2019 Pi is 0002937813006261

    6/17

    in t(e articiant use

    R#0 referent: 1 U U

    #0 an/ R40 1.#1 0.94e1.1 .11

    40 ".> 1.>e#.0 R .001

    ,iabetes mellitus 1.>4 1.0e"."4 .0"

    a)a&arotomy inclu/e/ total ab/ominal (ysterectomy an/ su&racer8ical (ysterectomy-

    b)a&arosco&ic incisions inclu/e/

    la&arosco&icassiste/ 8aginal (ysterectomy+ total la&arosco&ic (ysterectomy+ an/ la&arosco&ic su&racer8ical (ysterectomy.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

  • 7/24/2019 Pi is 0002937813006261

    7/17

    A)E #

    ,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8e /ee or organsace surgical siteinfection after (ysterectomy nC 1#+"":

    Variable

    $urgical site infection

    ,ee&Iorgans&ace

    nC 1>4:

    No /ee&Iorgans&ace

    nC 1#+: % 8alue

    Age+ n B: 1.0

    R0 y 1>" 9.: 1#+444 9.4:

    0 y " 1.#: ""4 1.:

    !ace6 '(ite+ n B: # 4.4: #"1 0.9: .001

    Et(nicity6 2is&anic+ n B: #" "0.: "1> 1>.9: .1"

    ,iabetes mellitus+ n B: "# 14.9: 1000 .#: R .01

    2istory of cerebro8ascular acci/ent 'it( neurologic /eficit+ n B: 4 ".: " 0.>: R .01

    3urrent smo*er+ n B: 4 #0.>: "> 19.: .001

    o/y mass in/e+ n B: R .001

    R#0 *gIm"

    44.": 0 >>.:

    #0 an/ R40 *gIm"

    >0 #".>: 4> ##.:

    40 *gIm"

    # "#.4: 14" 10.:

    Ascites+ n B: 4 ".: 10 0.: .04

    ;nintentional 'eig(t loss+ n B:a

    " 1.#: 4 0.>: .1

    unctional status6 /e&en/ent for acti8ities of /aily li8ing+ n B: " 1.#: 9 0.: .#0

    2ysterectomy for gynecologic cancer+ n B: 1# .4: 90 .>: .#"

    %reo&erati8e anemia6 (ematocrit 9R#B:+n B: >0 ##.: "94 "".: R .01

    %reo&erati8e creatinine F1.>mgI/)+ n B: # ".: > 0.9: .0

    American $ociety of Anest(esiologists class #+ n B: >4 #>.1: ">0 1.: R .001

    5ntrao&erati8e bloo/ transfusion+ n B: >.": ## ".>: .0

    =or* relati8e 8alue unitb

    1. 4. 1.# #. .1#

    O&erati8e time6 F>t(&ercentile /uration+ n B: >1 ##.1: #4"0 ">.0: .0#

    y&e of anest(esia6 general+ n B: 14 9.1: 1#+14 9.>: ."

    =oun/ class+ n B: .1

    13lean 0 ## 0.":

    "3leanIcontaminate/ 1>0 9.4: 1#+>0 9.:

    #3ontaminate/ # ".0: 94 0.:

    4,irty 1 0.: ## 0.":

    a)oss of 10B of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-

    b,ata are gi8en as mean $,.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

    before (ysterectomy n @ 1>:+ 4:3%

    4 co/e inconsistent 'it( (ysterectomy

    n @ 94#:+ >: 3%4 co/e t(at in/i

    cate/ el8ic eenteration roce/ure att(e time of (ysterectomy n @ 10:+ an/

    : 'omen 'it( /iagnosis of &reo&

    erati8e infection t(at inclu/e/

    sesis+ systemic inammatory

    resonse syn /rome+ an/ setic

    s(oc* imme/iately

    before (ysterectomy n @ 14":. A total of

    1#+"" 'omen un/er'ent (ysterectomy

    an/ 'ere inclu/e/ in our Knal analysis.

    3ellulitis(e o8erall occurrence of cellulitis

    suerKcial $$5: after (ysterectomy 'as

  • 7/24/2019 Pi is 0002937813006261

    8/17

    1.B nIN @ ""1I1#+"":. our 'omen

    0.0#B: recei8e/ a /iagnosis of bot(ostoerati8e cellulitis an/ /ee or

    organs&ace $$5. 'el8e 'omen

    0.0B: recei8e/ a /iagnosis of bot(

    &ost oerati8e cellulitis an/ ;5.

    Variables t(at 'ere associate/ 'it(

    cellulitis on bi8ariate analysis

    inclu/e/ /iabetes mellitus % R .

    001:+ M5 category % R

    .001:+ reoerati8e ascites % R .

    01:+ unintentional 'eig(t loss % @.0":+

  • 7/24/2019 Pi is 0002937813006261

    9/17

    (ysterectomy for cancer % R .001:+

    A$A class # % R .001:+ 'or* relati8e

    8alue unit % R .001:+ use of general

    anest(esia % @.001:+ an/ an o&erati8e

    time F>t( ercentile % R .001- able

    1:.

    A)E 4

    )ogistic regression mo/el for association of /ee or organ s&acesurgical site infection after (ysterectomy

    A/7uste/ o//s

    Variables t(at 'ere associate/ 'it(#0/ay ostoerati8e cellulitis on mul

    ti8ariate logistic regression 'ere t(e route

    VariableAmerican $ociety of Anest(esiologists

    class #

    ratio 9>B 35 % 8alue1.1 1.">e"." R .01

    of (ysterectomy 'it( an AO! of #.4

    3urrent smo*er 1.99 1.40e".# R .0019>B 35+ "."e."": for laarotomy in

    cisions comare/ 'it( 8aginal a&&roac(+

    oerati8e time F>t( ercentile

    AO!+

    2istory of cerebro8ascular acci/ent'it( neurologic /eficit

    4.41 1.>4e1".> R .01

    1.4- 9>B 35+ 1.40e".44:+A$A class #

    AO!+ 1.9- 9>B 35+ 1.#1e".4#:+

    morbi/ obesity M5+ 40 *gIm"-

    AO!+ ".>-9>B 35+ 1.>e#.0:+ an/ /iabetes mel

    litus AO!+ 1.>4- 9>B 35+ 1.0e"."4-

    able ":.

    ,ee& an/ organsace $$5

    (e occurrence of /ee an/ organ

    sace

    $$5 'as 1.1B nIN @ 1>4I1#+"": after

    %reo&erati8e anemia (ematocrit+ R#B: 1." 1."1e".4# R .01

    o/y mass in/e+ *gIm"

    R#0 referent: 1 U U

    #0 an/ R40 1.19 0."e1.4 .#

    40 "."# 1.4#e#.49 R .001

    35+confi/ence inter8al.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

    (ysterectomy. No 'omen 'ere catego

    riHe/ as (a8ing bot( a /ee s&ace $$5

    an/ an organsace $$5. 'entyone

    'omen 0.1B: 'ere /iagnose/ 'it(bot( &ost o&erati8e /ee&Iorgans&ace$$5 an/ ;5. Variables t(at 'ereassociate/ 'it( /ee an/ organs&ace$$5 on bi8ariate analysis inclu/e/ race% @ .001:+ /iabetes mel litus % R .

    01:+ (istory of 3VA 'it( neurologic

    /eKcit % R .01:+ current smo*ing %

    @ .001:+ obesity category % @ .11:+

    reoerati8e ascites % @ .04:+

    reoerati8e anemia % R .01:+ A$A

    class # % R .001:+ an/ an oerati8e

    time F>t( ercentile % @ .0#- able

    #:.

    Variables t(at 'ere associate/ 'it(

    /ee& an/ organs&ace $$5 on

    multi8ariate logistic regression inclu/e/

    A$A class # AO!+ 1.1- 9>B 35+

    1.">e".":+current smo*ing AO!+

    1.99- 9>B 35+

    1.40e".#:+(istory of 3VA 'it( neuro

    logic /eKcit AO!+ 4.41- 9>B 35+

    1.>4e1".>:+ &reo&erati8e anemiaAO!+

    1."- 9>B 35+ 1."1e".4#:+ an/ morbi/

    obesity AO!+ "."#- 9>B 35+1.4#e#.49- able 4:. =(en 'e

    eamine/ (ysterec tomy route+ bot(

    by ab/ominal incisions an/ by

    8aginal cuff incisions+ 'it( /ee an/

    organs&ace $$5+ 'e /i/ not Kn/ anysigniKcant associations.

    ;

    45

    %ostoerati8e ;5 occurre/ in ".B

    of 'omen nIN @ #0I1#+"":

    after

    (ysterectomy. Variables t(at 'ere asso

    ciate/ 'it( ostoerati8e ;5 on bi8ar

    iate analysis inclu/e/ (istory of 3VA

    'it( neurologic /eKcit % @ .01:+ A$A

    class # % R.01:+ an/ an o&erati8e time

    F>t( ercentile % R .001- able >:.

    Variables t(at 'ere associate/ 'it( &ost

    oerati8e ;5 on multi8ariate logistic

    regression 'ere a (istory of 3VA 'it(

    neurologic /eKcit AO!+ #."9- 9>B 35+

    1.41e.0:+ current corticosteroi/ use

    AO!+ ".#- 9>B 35+ 1.14e4.90:+ an/

    oerati8e time F>t( ercentile AO!+

    1.- 9>B 35+ 1.>"e"."9-able :.

    Occurrence of $$5by route of

    (ysterectomy

    =(en 'e eamine/ /ifferent routes

    of (ysterectomy A2+ $32+ )2+

    )A$32+ )AV2+ an/ V2:+ 'e notice/

    similarities in t(e occurrence of $$5

    by ab/ominal incision ty&e able :. =e

    eamine/ routes of (ysterectomy solely

    base/ on ab/ominal incisions la&arot

    omy+ laaroscoic incisions+ an/ no

    ab/ominal incisions: an/ note/ t(at t(e

    route of (ysterectomy 'as associate/

    'it( su&erKcial $$5+ but not /ee&Iorgan

    sace $$5 or ostoerati8e ;5. inally+

    'e eamine/ t(e association of &ost

  • 7/24/2019 Pi is 0002937813006261

    10/17

    (ysterectomy $$5 by t(e resence or

    absence of 8aginal cuff incisions $32 8s

    8aginal colotomy: an/ foun/ no asso

    ciation 'it( any ostoerati8e $$5.

    3OMMEN

    =e foun/ t(e o8erall occurrence of

    bot(

    #0/ay cellulitis suerKcial $$5:

    an/ /ee an/ organsace $$5 after

    (yster ectomy to be ".B. (e

    occurrence of ;5 after (ysterectomy

    'as #.0B.

    (e follo'ing ris* factors 'ereassoci ate/ 'it( t(e occurrence of

    ostoerati8e cellulitis6 (ysterectomy

    route+ oerati8e time F>t(

    ercentile 149 minutes:+ A$A class

    #+ /iabetes mellitus+ an/ obesity

    category M5+ 40 *gIm":. =e /i/

    not Kn/ smo*ing status or (ysterec

    tomy for gynecologic cancer to be

    in/e en/ent ris* factors for

    ostoerati8e cellulitis.

    Our Kn/ing of t(e /ecrease/

    occur rence of suerKcial $$5 aftert(e 8aginal aroac( for (ysterectomy

    reafKrms t(e longareciate/ role for

    8aginal (yster ectomy as t(e route of

    c(oice for (yster ectomy.141

    )aarotomy in/een/ently increase/

    t(e ris* of suerKcial $$5 after(ysterectomy. A tren/ 'as seen for

    increase/ $$5 'it( trocar incisions

    minimally in8asi8e (ysterectomies:+

    but t(is 'as not statistically signiKcant.

    Our Kn/ings a// to re8ious

    'or* 'it( National 2ealt(care $afetyNet'or* N2$N: /ata to eamine

    $$5."+1

    (e N2$N is an internet

    base/ sur8eillance systemt(at isuse/by t(e 3,3 to monitor (osital

    acuire/ infections t(at inclu/e $$5.1

    Originally+ t(e N2$Nbase/ ris*

  • 7/24/2019 Pi is 0002937813006261

    11/17

    A)E >

    ,emogra&(ic an/ clinical c(aracteristics of #0/ay ostoerati8e urinary tract infection after (ysterectomynC 1#+"":

    Variable;rinary tract infectionnC 40":

    No urinary tractinfection nC 1#+4"0: % 8alue

    Age+ n B: .1

    R0 y #9" 9.>: 1#+"04 9.4B:

    0 y 10 ".>: "1 1.B:

    !ace6 '(ite+ n B: ">9 4.4: 1#> 0.B: .1#

    Et(nicity6 2is&anic+ n B: > 14.": "1>0 1.0B: .#

    ,iabetes mellitus+ n B: "# >.: 1000 .>: ."1

    2istory of cerebro8ascular acci/ent 'it( neurologic/eficit+ n B:

    1.>: 0 0.>: .01

    3urrent smo*er+ n B: 90 "".4: "#" 19.: .1

    o/y mass in/e .4"

    R#0 *gIm"

    "1> >#.>: 41 >>.:

    #0 an/ R40 *gIm"

    14 #.: 4491 ##.>:

    40 *gIm"

    40 10.0: 14 10.9:

    Ascites+ n B: " 0.>: 10 0.: .

    ;nintentional 'eig(t loss+ n B:a

    4 1.0: " 0.>: .1#

    unctional status6 /e&en/ent for acti8ities of /ailyli8ing+ n B:

    1.>: 9# 0.: .0

    2ysterectomy for gynecologic cancer+ n B: " .>: .>: 1.00

    %reo&erati8e anemia6 (ematocrit 9R#B:+n B: 9 "0.: "94> "".9: .#"

    %reo&erati8e creatinine F1.>mgI/)+ n B: # 1.": > 0.9: .>1

    American $ociety of Anest(esiologists class #+ n B: 99 "4.: ">1> 1.: R .01

    5ntrao&erati8e bloo/ transfusion+ n B: 9 ".": ##> ".>: .

    =or* relati8e 8alue unitb

    1.1 #. 1.# #. .##

    O&erati8e time6 F>t(&ercentile /uration+ n B: 1># #.1: ##1 "4.: R .001

    y&e of anest(esia6 general+ n B: #9# 9.: 1"+9#9 9.4: .1

    =oun/ class+ n B: .

    13lean 0 ## 0.#:

    "3leanIcontaminate/ #9 99.0: 1#+"0 9.:

    #3ontaminate/ # 0.: 94 0.:

    4,irty 1 0.#: ## 0.#:

    a)oss of 10B or more of bo/y 'eig(t in t(e &re8ious mont(s not because of eercise or /ieting-

    b,ata are gi8en as mean $,.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

    a/7ustment for all $$5 'as base/ on t(e

    re/icti8e mo/el of 3ul8er et al11

    t(at

    incororate/ 'oun/ classiKcation+

    A$A classiKcation+ an/ oerati8e time.;sing t(ese ris* factors+ E/'ar/s et al

    "

    analyHe/ nearly 000 (ysterectomies

    t(at 'ere reorte/ to t(e N2$N.

    (e occurrence of all ostoerati8e

    $$5 suerKcial+ /ee

    an/ organsace: after V2 'as 0.9B

    an/ after A2 'as 1.B. ;nli*e t(e

    reorts by 3ul8er et al an/ E/'ar/s et al+

    our stu/y soug(t to i/entify ris* factorsfor $$5 t(at are more seciKc to (ysterectomy. y eamining 8arious ossible

  • 7/24/2019 Pi is 0002937813006261

    12/17

    ris* factors+ our stu/y suggests a//itional

    ris* factors+ suc( as route of

    (ysterectomy+

    &reo&erati8e anemia+ smo*ing status+

    an/ (istory of 3VA t(at s(oul/ be

    consi/ere/ in future stu/ies t(at

    eamine $$5 after (ysterectomy.

    Our Kn/ings are base/ on multi

    institutional /ata t(at 'ere

    collecte/ in a stan/ar/iHe/ fas(ion.

    Olsen et al#erforme/ a multicenter

    retrosecti8e

  • 7/24/2019 Pi is 0002937813006261

    13/17

    A)E

    )ogistic regression mo/el for association of urinary tract infection after(ysterectomy

    A/7uste/

    of t(e incision at t(e 8aginal cuff.

    After a (ysterectomy+ an eamle of a

    /ee $$5 'oul/ be consi/ere/ a

    8aginal cuff abscess. =e belie8e t(at a

    &el8ic abscess t(at /rains t(roug( t(e

    8aginal cuff+

    Variable2istory of cerebro8ascularacci/ent 'it( neurologic /eficit

    o//s ratio 9>B 35 % 8alue#."9 1.41e.0 R .01

    '(ic( 'oul/ be consi/ere/ as a /eesace $$5 /raining t(roug( t(esurgical incision+ is essentially similar

    to a el8ic

    3urrent corticosteroi/ use ".# 1.14e4.90 .0"

    O&erati8e time F>t(&ercentile /uration 1. 1.>"e"."9 R .001

    35+confi/ence inter8al.

    )a*e. $urgical site infections after (ysterectomy. Am J Obstet Gynecol "01#.

    abscess t(at reuires /rainage t(roug(

    inter8entional ra/iology+ '(ic( alter

    nati8ely 'oul/ be categoriHe/ as an

    organsace $$5. ecause of t(e o8erla

    bet'een t(ese terms+ 'e electe/ to

    combine /ee an/ organsace $$5.

    (e ris* factors associate/ 'it(&ost

    casecontrolle/ stu/y 'it( a&&roi

    mately 00 atients after A2 an/V2. (e cases an/ control sub7ects

    'ere collecte/ 'it( t(e use of t(e

    5nternational 3lassiKcation of,iseases+ Nint( !e8i sion+ 3linical

    Mo/iKcation &roce/ure co/es for

    (ysterectomy from 4 artici ating

    3,3 %re8ention Eicenter %ro gram

    (ositals from "00#"00>. ot( M5

    F#> *gIm"

    an/ intraI&ostoerati8e

    bloo/ transfusion 'ere i/entiKe/ as

    in/een/ent ris* factors for suerKcial

    $$5 after (ysterectomy 'it(laarotomy. $imilarly+ a singleinstitution c(art re8ie' also foun/

    obesity M5+ #0 *gIm": an/ bloo/

    transfusion re+ intra+ an/

    ostoerati8e: to be associate/ 'it( all

    $$5 after ab/ominal (ysterectomy.4

    2o'e8er+ ot(ers (a8e foun/ obesity

    not to be a ris* factor for

    osto&erati8e comlications after

    gynecologic sur gery.19

    =e foun/

    t(at+ by consi/ering M5 F#0 *gIm"+

    M5 'as i/entiKe/ as a ris*factor forsu&erKcial $$5 cellulitis:. 5n our larger

    multicenter analysis+ 'e /i/ not Kn/ an

    associationbet'een&re oerati8etransfusion an/ $$5. Alt(oug(

    intraoerati8e transfusion 'as i/entiKe/

    in our bi8ariate analysis to be associate/

    'it( cellulitis an/ /eeIorgansace $$5+'e /i/ not Kn/ a statistically signiKcant

    association bet'een intraoerati8e

    trans fusion an/ $$5 after a/7usting

    for ot(er 8ariables. (e /ifferences in

    our Kn/ings an/ re8ious reortsregar/ing trans fusion bot( re an/

    intraoerati8e: as a ris* factor for $$5

    after (ysterectomy li*ely are relate/ to

    t(e robust sam&le siHeof our

    stu/y.

    =e i/entiKe/ ris* factors t(at

    'ere associate/ 'it( /ee an/

    organs&ace

    $$5 after (ysterectomy t(at inclu/e/

    &reo&erati8e anemia an/ (istory of 3VA+'(ic( may be reecti8e of c(ronic &re

    oerati8e systemic /isease. (ese ris*

    factors are in a//ition to ris* factors of

    A$A class #+ current smo*ing status+

    an/ morbi/ obesity M5+ 40 *gIm":.

    =e /i/ not Kn/ a statistically signiKcant

    /ifference in /ee an/ organsace $$5

    bet'een /ifferent (ysterectomy routes.

    =e (yot(esiHe t(at our Kn/ings of

    increase/ association of bot( &reo&era

    ti8e anemia an/ (istory of 3VA 'it(

    /ee an/ organsace $$5 may reect a/ecrease of t(e bo/ySs ability to res&on/to stressors of surgery an/ to combat

    ostoerati8e infection. =e foun/ an

    association bet'een reoerati8e 3VA

    'it( resi/ual neurologic /eKcit an/ t(e

    ris* of /ee an/ organsace $$5. 3VA

    (as been note/ to be associate/ signiK

    cantly 'it( any a/8erse ostoerati8e

    e8ent."0

    =e belie8e t(at 'e may (a8e

    obser8e/ t(is relations(i because 3VA

    'it( resi/ual neurologic /eKcit is a ris*

    factor for functional /een/ence.

    "1

    3(enet al

    ""foun/ functional /een/ence to

    be an in/een/ent ris* factor for &ost

    oerati8e $$5+ seciKcally met(icillin

    resistant $ta&(ylococcus aureus $$5+ in

    ol/er a/ults.

    =e /i/ not Kn/ /ifferences in ris*

    factors for /ee an/ organsace $$5

    '(en 'e eamine/ t(ese infections se

    arately. =e ultimately c(ose to combine

    t(ese " categories '(en eamining

    $$5 after (ysterectomy. =e belie8e t(at

    /ee an/ organsace $$5+ alt(oug(/eKne/ /istinctly by t(e A3$ N$?5%

    an/ 3,3 criteria+ are functionally t(e

  • 7/24/2019 Pi is 0002937813006261

    14/17

    same e8ent after (ysterectomy because oerati8e ;5 after (ysterectomy 'ere

    a (istory of 3VA 'it( neurologic

    /eKcit+ c(ronic steroi/ use+ an/

    oerati8e time F>t( ercentile. =e

    foun/ t(e occurrence of #0/ay

    ostoerati8e ;5 'as #.0B n @

    40" 'omen: after (ys terectomy.

    ;nfortunately+ 'e /i/ not (a8e

    information on cat(eter use or

    /urationbecause of limits of t(e/ataset. One (un/re/ fortyt'o

    'omen 'ere i/entiKe/ as (a8ing

    reoerati8e sys temic infection

    t(at inclu/e/ se&sis+ se&tic s(oc*+

    an/ systemic inammatory resonse

    syn/rome an/ 'ere eclu/e/because

    of t(e in(erent /ifference in t(ese

    cases from 'omen '(o un/ergo

    sc(e/ule/ electi8e surgery.

    Alt(oug( t(ese con/itions may be

    associate/ 'it( a greater ris* of

    ostoerati8e $$5+ t(e small numbersan/ t(e 8arious /ifferent causes of

    systemic infection ma/e it /ifKcult

    to /ra' conclusions in t(e cur

    rent stu/y.

    Our stu/y (as many limitations.

    (e Krst is t(at our analysis 'as

    limite/ to t(e 8ariables t(at eiste/ in

    t(e /atabase. or eamle+ 'e 'ere

    limite/ by t(e A3$ N$?5%

    /eKnition of /ee an/ organsace

    $$5- t(erefore+ 'e 'ere also unable to

    /istinguis( bet'een&el8ic ab scesses+8aginal cuff cellulitis+ or fasciitis.

    $econ/+ seciKc 8ariables 'ere not

    collecte/ in t(e general A3$N$?5% /ataset t(at 'oul/ (a8e

    en(ance/ our stu/y Kn/ings. or

    eamle+ t(e ty&e an/ timing ofreoerati8e&ro&(ylactic antibiotic

    a/ministration+ '(ic( is a factor

    lin*e/ to ostoerati8e infec

    tion+"#+"4

    'ere not a8ailable in t(e

    /atabase. Anot(er limitation of t(is

    /ataset 'as t(e lac* of informationabout t(e

  • 7/24/2019 Pi is 0002937813006261

    15/17

    4

    A)E

    A

    ll#0/ay&osto&erati8esurgical

    siteinfectionsan/urinarytractinfectionsby(ysterectomyroute

    n

    C

    1#+G

    "":

    4otalab/ominal

    (ysterectomy+

    nB

    :

    >0E9

    9#.G

    :

    141

    ".E

    :

    E

    1."

    :

    1"G

    ".4

    :

    $u&racer8ical

    (ysterectomy+

    nB:

    EGG94

    .0:

    1"

    .#:

    G1

    .1:

    19"

    .E:

    4otal8aginal

    (ysterectomy+

    nB:

    "9"19>.#

    :

    10

    .E:

    #"1

    .0:

    94#

    .1:

    )a&arosco&icassiste/

    8aginal

    (ysterectomy+n

    B:

    "09494.#

    :

    10

    .:

    ##1

    .>:

    E#

    .4:

    4otalla&arosco&ic

    (ysterectomy+

    nB:

    G#9>."

    :

    >0

    .E:

    40

    .>:

    ###.G

    :

    )a&

    arosco&ic

    su&racer8ical

    (ysterectomy+nB:

    14

    "9E.

    :

    "

    01

    .#:

    100

    .:

    "01

    .#:

    4y&eo

    fsurgical

    siteinfection

    None3

    ellulitis

    ,ee&Io

    rgan0s&ace

    ;rinary

    tract

    infection

    n 1#

    +01

    94

    .E:

    "11

    .E:

    1>41

    .1:

    #0"

    .:

    )a*e.

    $urgicalsiteinfectionsafter(ysterectomy.

    Am

    JObstetG

    ynecol"01#.

    in/ication for (ysterectomy. $urgical

    roce/ures 'ere categoriHe/ by 3%

    co/es alone. (e occurrence of &ost

    oerati8e ;5 after rolase or anti

    incontinence surgery (as been re&orte/

    to be (ig(er t(an t(at foun/ in our

    stu/y.">

    ecause t(e 'omen 'ereselecte/ for inclusion in t(is stu/y base/

    on (ysterectomy an/ not rolase or

    incontinence roce/ures+ 'e 'ere not

    able to /etermine t(e occurrence of

    ;5 after rolase or incontinence&ro

    ce/ures in our current analysis.

    =e /i/ not Kn/ an association 'it(

    (ysterectomies t(at 'ere erforme/

    for gynecologic cancer an/ $$5 base/

    on 3%4 co/es. (is Kn/ing may also

    be /ue to t(e lac* of s&eciKc

    information in t(e /ataset regar/ingcancer stage+ gra/e+ an/ at(ologic

    con/ition in t(e A3$ N$?5% /ataset.

    =e 'ere limite/ to t(e i/entiKcation of

    roce/ures for gyneco logic cancer

    base/ on 3%4 co/es t(at in/icate/

    ra/ical /issection an/ lym(a

    /enectomies. A//itionally+ some

    (yster ectomies for cancer t(at

    reuire/ bo'el resection may (a8e

    been co/e/ rimarily as colon surgery

    an/ t(erefore not inclu/e/ in our

    analysis. =e /i/ eamine all cancer8ariables t(at 'ere a8ailable in t(e

    A3$ N$?5% /ataset inclu/ing *no'n

    /isseminate/ tumor+ c(emo t(eray+

    or ra/iation t(eray 'it(in

    #0 /ays before roce/ure an/ *no'n

    central ner8ous system tumor: bot(

    in/i8i/ually an/ as a comosite grou&

    an/ /i/ not Kn/ a statistically

    signiKcant association 'it( $$5. (is+

    again+ li*ely reects t(e limitation of

    t(e /ataset because it /oes not inclu/e

    cancer stage+ gra/e+ an/ /isease.

    )ast+ (osital articiation in t(e

    A3$ N$?5% is 8oluntary an/ conK/en

    tial+ '(ic( may intro/uce selectionbias-

    (o'e8er+ as of "009+ F#"0 (os&itals

    'ere articiating in t(e A3$ N$?5%

    &ro gram+ '(ic( inclu/e/ a 'i/e

    range of community (ositals an/

    tertiary care centers. (e A3$ N$?5%

    &artici&antuse /ata Kles /o not allo'

    for i/entiKcation of articiating

    (ositals 'it(in t(e /ataset- t(erefore+

    'e 'ere not able to account for t(e

    effect of clustering of obser8ations'it(in centers. 2o'e8er+ re8ious

    in8

    est

    iga

    tor

    s

    (a

    8e/e

    mo

    n

    str

    ate

    /

    t(a

    t

    t(e

    clu

    ste

    ring

    eff

    ect

    fro

    m

    t(e

  • 7/24/2019 Pi is 0002937813006261

    16/17

    A$3 N$?5% for ot(er en/oints is minimal an/ /i/ not c(ange t(e o8erall

    a/7uste/ outcomes.>+"

    Our stu/y suggests t(at numerous factors+ '(ic( inclu/e (ysterectomy route+

    oerati8e time+ /iabetes mellitus+ A$A class #+ M5+ smo*ing status+ &re

    oerati8e anemia+ 3VA 'it( neurologic /eKcit+ an/ corticosteroi/ use are associ

    ate/ 'it( $$5 after (ysterectomy. ,e8el oment of a &re/icti8e mo/el for $$5

    after all tyes of (ysterectomy is nee/e/. ;nfortunately+ 'e cannot /e8elo a

    &re /icti8e mo/el 'it( t(is current 'or* because of a lac* of a 8ali/ation

    co(ort.

    ,ecreasing re8entable (os&ital acuire/ infections is imortant for t(esa*e of uality atient care. 5n lig(t of t(e recent national 3M$ man/ate t(at

    reuires all Me/icarecertiKe/ (ositals to reort /ata an/ outcome measures

    &ublicly+ t(e re8ention of $$5 'ill soon become imortant for a (ositalSs

    Knancial stability as 'ell.1

    (e A3$ N$?5% rogram to imro8e uality an/

    atient safety (as succee/e/ by &ro 8i/ing timely+ consistent+ conK/ential+

    ris*a/7uste/ fee/bac* to articiating institutions on t(e institutional occur

    rence of a 'i/e range of ostoerati8e comlications.>

    5nstitutions imme/i ately

    can i/entify systems an/ strategies to imro8e atient outcomes in outlying areas.>

    (is conK/ential ris*a/7uste/ rogram (as begun to imro8e surgical outcomes.

    no'le/ge of t(e baseline occurrence of ostoerati8e $$5 after /ifferent

    routes of (ysterectomy an/ associate/ ris* factors is imortant to imro8e

    atient safety after (ysterec tomy by (eling to i/entify mo/iKable factors to

    re8ent $$5. ecause 3M$ enforces man/atory ublic re&orting of

    ostoerati8e $$5 after (ysterec tomy 'it(out ris* a/7ustment seciKc to

    (ysterectomy+ careful monitoring must be use/ to i/entify uninten/e/conseuences. 0

    !EE!EN3E$

    1. 3enters for Me/icare an/ Me/icai/ $er8ices 3M$:+ 22$. inal rule 3M$ 149. fe/eral

    register 8olume >+ number 1> Mon/ay+ august

    1+ "010:DCrules an/ regulationsD Cages >0041

    >0D from t(e fe/eral register online 8ia t(e go8ernment &rinting ofKce C' ' ' .g& o .g o8D

    http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/http://www.gpo.gov/
  • 7/24/2019 Pi is 0002937813006261

    17/17

    C! /oc no6 "0101909". A8ailable at6( tt& 6II

    '''.g&o.go8If/sysI&*gI!"01101I(tmlI

    " 0 1 1 1 9 1 9 .( tm. Accesse/ ,ec. 19+

    "01".

    ". E/'ar/s J!+ %eterson ,+ An/rus M)+ et al.

    National (ealt(care safety net'or* N2$N:

    reort+ /ata summary for "00 t(roug( "00.

    Am J 5nfect 3ontrol "00-#6 0 9" .

    #. Olsen MA+ 2ig(am essler J+ 9 #.

    . National 5nstitutes of 2ealt(. 3linical gui/e

    lines on t(e i/entiKcation+ e8aluat ion+ an/ treat

    ment of o8er'eig(t an/ obesity in a/ults6 t(e

    e8i/ence reort. Obes !es 199-su l ":6

    >1$"09 $.

    . =u =3+ $c(ifftner )+ 2en/erson =G+ et al.

    %reoerati8e (ematocr it le8els an/ &ost

    oerati8e outcomes in ol/er atients un/ergoing

    noncar/iac surgery. JAMA "00-"9 6"41 .

    9. 2 eisler 3 A + A le t ti G,+ =e a 8er A )+

    M e lt on )J # r /+ 3l i by =A+ Ge b (art J. 5m r o8 i ng

    u ality of ca r e6 /e 8 e l o& m ent of a ris *a /7ust e /e r io er a ti 8e mor bi/i ty mo / el f o r 8a gin al (y s

    te r ec t om y . A m J O b s te t Gy n ecol "0 10 -"0 "6

    1# .e1 >.

    10. ,o'/y $3+ ora( J+ a**umG a meH JN+

    et al. actors re/icti8e of &osto&e rati8e

    morbi/ity an/ cost in atients 'it( en/ome trial

    cancer. Obstet Gynec o l"01"-1"06 1419" .

    11. 3ul8er ,2+ 2oran 3+ Gaynes !%+ et al.

    $urgical 'oun/ infection rates by 'oun/ class+

    oerati8e &roce/ure+ an/ atient ris* in/e6

    National Nosoc o mial 5nfectio n s $ur8eillance$ystem. Am J Me/ 1991-916 1>"$ $.

    1". American 3ollege of $urgeons National

    $ur gical ?uality 5mro8ement %rogram.

    %artici&ant use /ata Kle. A8ailable at6

    ( tt& 6IIsite .ac sn s i&.o rgI &a r tici&a ntu s e /a ta

    KleI. Accesse/ Aug. 1>+

    "01".

    1#. 2oran 3+ An/rus M+ ,u/ec* MA. 3,3I

    N2$N sur8eillan c e /eKnition of (ealt( care

    associat e / infection an/ criteria for s&eciKc

    tyes of infections in t(e acute care setting. Am J

    5nfect 3ontrol "00-#6# 0 9#".

    14. o8a c $ ! . G u i/ e line s to /etermin e t( eroute

    o f ( y st ere c to m y . Ob st e t Gy necol 19 9 >- >61 " #.

    1>. alc on e + = alt e r s M, . 2 y ster e cto m y fo r

    b e n ig n /is ease. O b st e t G yne col

    " 0 0-1 11 6 > # .

    1. American 3ollege of Obstetri c ians an/ Gy

    necologi s ts. A3OG committee oinion no. 4446

    c(oosing t(e route of (ysterect o my for benign

    /isease. Obstet Gynecol "009-1146 1 1>.

    1. Mu + "01".

    19. 3(en 33+ 3ollins $A+ !o/gers A+

    %araiso M+ =alters M,+ arber M,.

    %erioera ti8e comli c ations in obese 'omen 8s

    normal'ei g (t 'omen '(o un/ergo 8aginal

    surgery. Am J Obstet Gynecol "00- 1 969.

    e1.

    "0. )iu ))+ )eung JM. %re/icting a/8erse

    &osto&erat i8e outcom e s in atients age/ 0

    years or ol/er. J Am Geriatr $oc "000-46

    40>1 ".

    "1. ernan / es G+ Goulart A3+ $antosJunior =!+ Alencar A%+ ensenor 5M+ )otufo %A.

    E/ucational le8els an/ t(e function al /e&en

    /ence of isc(emic stro*e sur8i8ors. 3a/ $au/e

    %ublica "01"-"61 > 190.

    "". 3(en


Recommended